glp 1 drugs and fatty liver GLP-1 Receptor Agonists in Non-Alcoholic Disease: Current Evidence Future Perspectives Therapeutic Effects of Glucagon-like Peptide-1

GLP-1 receptor agonists the treatment of type 2 diabetes: state-of-the-art

Focus on nutrient-dense foods that provide essential vitamins, minerals, and macronutrients in smaller volumes

doi: 10.1111/j.1463-1326.2007.00733.x

"Our study highlights several biological pathways by which GLP1 drugs may influence Alzheimer's, including reducing inflammation, improving insulin signaling in the brain, and altering enzymes involved in the production of amyloidbeta." GLP-1 drugs get their name from the glucagon-like peptide-1 (GLP-1) hormone that they mimic

The human GLP-1 analog liraglutide and the pancreas: evidence for the absence of structural pancreatic changes in three species

This does not constitute medical advice